Nevertheless, in early cross-sectional studies of PD cohorts, a lower baseline DAT binding correlated with the increasing disease duration and motor severity measured by the UPDRS and the Hoehn and Yahr stadium [11,208,209,210] (Table 1). This evidence concerns the gene SLC6A3 and Parkinson disease.